Portnoy Law Firm Announces Class Action on Behalf of Telix Pharmaceuticals Limited Investors
(NASDAQ:TLX), LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Telix Pharmaceuticals Limited, (“Telix” or the “Company”) (NASDAQ: TLX) investors off a class action on behalf of investors that bought securities between February 21, 2025 and August 28, 2025, inclusive (the “Class Period”). Telix investors have until January 9, 2026 to […]